Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
AO Williams, OA Makinde, M Ojo - Global health research and policy, 2016 - Springer
Abstract Background Multidrug drug resistant Tuberculosis (MDR-TB) and extensively drug
resistant Tuberculosis (XDR-TB) have emerged as significant public health threats …
resistant Tuberculosis (XDR-TB) have emerged as significant public health threats …
Pharmacophore modelling, QSAR study, molecular docking and insilico ADME prediction of 1, 2, 3-triazole and pyrazolopyridones as DprE1 inhibitor antitubercular …
D Panigrahi, A Mishra, SK Sahu - SN Applied Sciences, 2020 - Springer
Tuberculosis (TB) is a chronic lung infected airborne disease caused by Mycobacterium
tuberculosis (MTB). The development of resistance towards available antitubercular agents …
tuberculosis (MTB). The development of resistance towards available antitubercular agents …
[HTML][HTML] The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-resistant tuberculosis in two regions of Ethiopia
Y Molla, D Jerene, I Jemal, G Nigussie… - Journal of clinical …, 2017 - Elsevier
Strong strategies, including proven service delivery models, are needed to address the
growing global threat of multidrug-resistant tuberculosis (MDR-TB) in low-and middle …
growing global threat of multidrug-resistant tuberculosis (MDR-TB) in low-and middle …
[HTML][HTML] Home based care as an approach to improve the efficiency of treatment for MDR tuberculosis: a quasi-experimental pilot study
N Taneja, VG Chellaiyan, S Daral… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Aim To assess the outcome of Home-Based Care (HC) versus No Home-Based Care (NHC)
on the treatment of MDR TB patients registered at two chest clinics in Eastern Delhi …
on the treatment of MDR TB patients registered at two chest clinics in Eastern Delhi …
Cost effectiveness of decentralised care model for managing MDR-TB in India
Abstract Background In India, multidrug-resistant tuberculosis (MDR-TB) patients are usually
treated in hospitals. Decentralised care model, however, has been suggested as a possible …
treated in hospitals. Decentralised care model, however, has been suggested as a possible …
[PDF][PDF] 3VHZALP/9VHZL 化疗方案联合经纤维支气管镜介入治疗耐多药肺结核并支气管结核的临床疗效
高云 - 实用心脑肺血管病杂志, 2016 - boyuancaibian.oss-cn-beijing …
目的观察3VHzALP/9VHzL 化疗方案联合经纤维支气管镜介入治疗耐多药肺结核并支气管结核
的临床疗效. 方法选取2013 年8 月—2014 年8 月河北大学附属医院收治的耐多药肺结核并 …
的临床疗效. 方法选取2013 年8 月—2014 年8 月河北大学附属医院收治的耐多药肺结核并 …
Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
M Muniyandi, R Ramachandran - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: India accounts for 25% of the global burden of MDR-TB. In 2016, the India's
Revised National TB Control Programme reported a success rate of 46% among 19,298 …
Revised National TB Control Programme reported a success rate of 46% among 19,298 …
Adverse Drug Reactions in Multi-Drug Resistant Tuberculosis Patients, in India, who had received DOTS Plus Treatment along with Home Care and Counselling
JF Vaghela - Medical Research Archives, 2024 - esmed.org
Background: Adverse drug reactions are common in MDR-TB patients on treatment. An
adverse drug reaction (ADR) is defined as an appreciably harmful or unpleasant reaction …
adverse drug reaction (ADR) is defined as an appreciably harmful or unpleasant reaction …
经纤维支气管镜局部注射辅助治疗耐多药肺结核效果评价
高云 - 临床输血与检验, 2017 - lcsxyjy.com
目的探讨经纤维支气管镜局部注射辅助治疗耐多药肺结核的效果及对免疫功能的影响.
方法选择2013 年3 月~ 2014 年3 月本院收治的98 例耐多药肺结核患者, 按照治疗方案不同分为 …
方法选择2013 年3 月~ 2014 年3 月本院收治的98 例耐多药肺结核患者, 按照治疗方案不同分为 …